Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Living Cell Technologies to Cancel Rights at $O.20

Living Cell Technologies to Cancel Rights at A$O.20 Following A$6M Placement at $0.30 Per Share

November 22, 2007 – Melbourne, Australia and Auckland, New Zealand -Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced that U.S.based NaviGroup Management Limited has conditionally agreed to waive its 90day right to purchase up to US$6 million of LCT’s ordinary shares at $A0.20 per share, retaining its right to purchase up to US$6 million of LCT’s ordinary shares at 80% of the 30 day average closing bid price for an ordinary share of LCT.

NaviGroup’s waiver of its right to purchase LCT’s ordinary shares at A$0.20 per share is subject to the completion of the previously announced A$6 million placement of LCT ordinary shares by Taylor Collison Limited. Pursuant to the Placement Agreement,Taylor Collison has exercised its right to reduce the placement price from 36 cents to 30 cents per share so that it more closely reflects LCT’s share price at the present time. NaviGroup’s right to purchase additional shares in LCT and the Taylor Collison placement are subject to shareholder approval at the general meeting of shareholders on November 27, and other terms and conditions.

Funds from placements by NaviGroup and Taylor Collison would be used to further LCT’s DiabeCell® clinical trials in Russia and New Zealand, as well as expanding the Company’s infrastructure to meet clinical trial requirements.

LCT’s Chief Financial Officer, Richard Justice said “The changes to the NaviGroup option and the Taylor Collison placement make the terms of LCT’s announced financings more equitable to shareholders and the two groups concerned. The fact that we have U.S. and Australian investors involved demonstrates the strong interest that is being generated in the Company globally.”

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Half A Billion Accounts: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>

Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>

ALSO:

Half Full: Fonterra Raises Forecast Payout As Global Supply Shrinks

Fonterra Cooperative Group, the dairy processor which will announce annual earnings tomorrow, hiked its forecast payout to farmers by 50 cents per kilogram of milk solids as global supply continues to decline, helping prop up dairy prices. More>>

ALSO:

Results:

Meat Trade: Silver Fern Farms Gets Green Light For Shanghai Maling Deal

The government has given the green light for China's Shanghai Maling Aquarius to acquire half of Silver Fern Farms, New Zealand's biggest meat company, with ministers satisfied it will deliver "substantial and identifiable benefit". More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news